News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Mihaela Aldea received a 2024 IASLC YIA
Photo from Mihaela Aldea/X
Jun 28, 2024, 04:59

Mihaela Aldea received a 2024 IASLC YIA

Mihaela Aldea, Medical Oncologist at the Gustave Roussy, shared a post on X:

“Honored to receive a 2024 IASLC YIA (Young Investigator Grants). Congrats to all awardees and friends Biagio Ricciuti, Alessio Cortellini and others.

Collaboration is key to help our patients. Thank you IASLC.”

Read further.
Source: Mihaela Aldea/X

Alessio Cortellini Benjamin Besse Biagio Ricciuti cancer Dana-Farber Gustave Roussy IASLC Mark Awad Mihaela Aldea OncoDaily Oncology YIA Young Investigator Grants
Special Coverage
Drugs
Dec 21, 2024, 10:38
Hanna Foster: Market cap and Revenue of Cancer NGS Drugs providers in 2024
Insight
Dec 21, 2024, 10:35
30 Years of Leadership in Immuno-Oncology - Agenus
Blog
Dec 21, 2024, 10:19
A Portrait of Germline Pathogenic Variants in Breast Cancer Genes in Brazil
Dialogues
Dec 21, 2024, 10:09
Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market
Blog
Dec 21, 2024, 09:22
When the world of science and sports comes together! - The V Foundation
Blog
Dec 21, 2024, 09:16
Timely cancer treatment isn’t just a goal, It’s a necessity - European Cancer Organisation
Science
Dec 21, 2024, 09:06
Toni Choueiri: The Final Analysis of the JAVELIN Renal 101 trial
Blog
Dec 21, 2024, 09:00
Miriam Mutebi: Does Nipple and Areola Size Matter?
Science
Dec 21, 2024, 08:51
Wafik S. El-Deiry: Our recent review on Targeting the SMURF2-HIF1α axis
Science
Dec 21, 2024, 08:48
Oncology Brothers: Another ALK inhibitor gets FDA approval
Science
Dec 21, 2024, 08:42
Eric K. Singhi: Decoding clinical trial jargon
Science
Dec 21, 2024, 08:37
Gustavo Viani: The Role of Radiotherapy on the management of HCC